ヒトマイクロバイオームの世界市場見通し:食品、薬品、プロバイオティクス、診断装置、プレバイオティクス、医療食

◆英語タイトル:Human Microbiome - Global Market Outlook (2016-2022)
◆商品コード:SMRC611017
◆発行会社(調査会社):Stratistics MRC
◆発行日:2016年10月
◆ページ数:168
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Single UserUSD4,150 ⇒換算¥464,800見積依頼/購入/質問フォーム
2-5 UserUSD5,250 ⇒換算¥588,000見積依頼/購入/質問フォーム
Global Site LicenseUSD7,500 ⇒換算¥840,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はStratistics MRC社の日本における正規販売代理店です。Stratistics MRC社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、ヒトマイクロバイオームの世界市場について調査・分析し、ヒトマイクロバイオームの世界市場規模、市場動向、関連企業分析などを含め、以下の構成でお届けいたします。
・エグゼクティブサマリー
・序文
・ヒトマイクロバイオームの世界市場:市場動向分析
・ヒトマイクロバイオームの世界市場:競争要因分析
・ヒトマイクロバイオームの世界市場:セグメント別分析/市場規模
・ヒトマイクロバイオームの世界市場:地域別分析/市場規模
・ヒトマイクロバイオームの北米市場規模
・ヒトマイクロバイオームの欧州市場規模
・ヒトマイクロバイオームのアジア市場規模
・ヒトマイクロバイオームの世界市場:主な市場開拓
・関連企業分析
【レポートの概要】

According to Stratistics MRC, the Global Human Microbiome Market is accounted for $130.23 million in 2015 and is expected to reach $521.23 million by 2022 growing at a CAGR of 21.9% during the forecast period. Increasing incidence of lifestyle diseases, growing geriatric population, and technological developments are some of the factors fueling the market growth. By product, Probiotics segment dominated the global market with largest share during the forecast period. North America and Europe commanded the market owing to the improved biotechnological and microbiological research infrastructure. However, Asia-Pacific is anticipated to grow at the highest CAGR owing to recuperating research infrastructure in the region.

Some of the key players in Human Microbiome market include Ritter Pharmaceuticals, Inc., E. I. du Pont de Nemours and Company, ViThera Pharmaceuticals, Metabiomics Corp., ActoGeniX, Optibiotix Health Plc, Vedanta Biosciences, Inc., MicroBiome Therapeutics, LLC, Second Genome, Inc., ENTEROME Bioscience, Yakult Honsha Co., Ltd., Osel, Inc., AvidBiotics, Rebiotix Inc., Merck & Co., Inc. and Seres Therapeutics.

Applications Covered:
• Diagnostics
• Therapeutics

Diseases Covered:
• Cancer
• Acute Diarrhea
• Diabetes
• Mental Disorders
• Autoimmune Disorders
• Obesity
• Other Diseases

Products Covered:
• Foods
• Drugs
• Probiotics
• Diagnostic Devices
• Prebiotics
• Medical Foods
o Nutritionally Incomplete Formulae
o Formulae for Metabolic Disorders
o Nutritionally Complete Formulae
o Oral Rehydration Products
• Other Probiotics Supplements

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK
o Spain
o Rest of Europe
• Asia Pacific
o Japan
o China
o India
o Australia
o New Zealand
o Rest of Asia Pacific
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

【レポートの目次】

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Application Analysis
3.7 Product Analysis
3.8 Research Scenario
3.9 Emerging Markets
3.10 Supply Chain Analysis
3.11 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Human Microbiome Market, By Application
5.1 Introduction
5.2 Diagnostics
5.3 Therapeutics

6 Global Human Microbiome Market, By Disease
6.1 Introduction
6.2 Cancer
6.3 Acute Diarrhea
6.4 Diabetes
6.5 Mental Disorders
6.6 Autoimmune Disorders
6.7 Obesity
6.8 Other Diseases

7 Global Human Microbiome Market, By Product
7.1 Introduction
7.2 Foods
7.3 Drugs
7.4 Probiotics
7.5 Diagnostic Devices
7.6 Prebiotics
7.7 Medical Foods
7.7.1 Nutritionally Incomplete Formulae
7.7.2 Formulae for Metabolic Disorders
7.7.3 Nutritionally Complete Formulae
7.7.4 Oral Rehydration Products
7.8 Other Probiotic Supplements

8 Global Human Microbiome Market, By Geography
8.1 North America
8.1.1 US
8.1.2 Canada
8.1.3 Mexico
8.2 Europe
8.2.1 Germany
8.2.2 France
8.2.3 Italy
8.2.4 UK
8.2.5 Spain
8.2.6 Rest of Europe
8.3 Asia Pacific
8.3.1 Japan
8.3.2 China
8.3.3 India
8.3.4 Australia
8.3.5 New Zealand
8.3.6 Rest of Asia Pacific
8.4 Rest of the World
8.4.1 Middle East
8.4.2 Brazil
8.4.3 Argentina
8.4.4 South Africa
8.4.5 Egypt

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Ritter Pharmaceuticals, Inc.
10.2 E. I. du Pont de Nemours and Company
10.3 ViThera Pharmaceuticals
10.4 Metabiomics Corp.
10.5 ActoGeniX
10.6 Optibiotix Health Plc
10.7 Vedanta Biosciences, Inc.
10.8 MicroBiome Therapeutics, LLC
10.9 Second Genome, Inc.
10.10 ENTEROME Bioscience
10.11 Yakult Honsha Co., Ltd.
10.12 Osel, Inc.
10.13 AvidBiotics
10.14 Rebiotix Inc.,
10.15 Merck & Co., Inc.
10.16 Seres Therapeutics

List of Tables
Table 1 Global Human Microbiome Market Outlook, By Region (2013-2022) ($MN)
Table 2 Global Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
Table 3 Global Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 4 Global Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 5 Global Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
Table 6 Global Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
Table 7 Global Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
Table 8 Global Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
Table 9 Global Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
Table 10 Global Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 11 Global Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
Table 12 Global Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 13 Global Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
Table 14 Global Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
Table 15 Global Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
Table 16 Global Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
Table 17 Global Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
Table 18 Global Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
Table 19 Global Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
Table 20 Global Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
Table 21 Global Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
Table 22 Global Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
Table 23 Global Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
Table 24 Global Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)
Table 25 North America Human Microbiome Market Outlook, By Country (2013-2022) ($MN)
Table 26 North America Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
Table 27 North America Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 28 North America Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 29 North America Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
Table 30 North America Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
Table 31 North America Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
Table 32 North America Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
Table 33 North America Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
Table 34 North America Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 35 North America Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
Table 36 North America Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 37 North America Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
Table 38 North America Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
Table 39 North America Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
Table 40 North America Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
Table 41 North America Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
Table 42 North America Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
Table 43 North America Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
Table 44 North America Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
Table 45 North America Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
Table 46 North America Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
Table 47 North America Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
Table 48 North America Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)
Table 49 Europe Human Microbiome Market Outlook, By Country (2013-2022) ($MN)
Table 50 Europe Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
Table 51 Europe Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 52 Europe Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 53 Europe Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
Table 54 Europe Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
Table 55 Europe Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
Table 56 Europe Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
Table 57 Europe Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
Table 58 Europe Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 59 Europe Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
Table 60 Europe Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 61 Europe Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
Table 62 Europe Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
Table 63 Europe Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
Table 64 Europe Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
Table 65 Europe Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
Table 66 Europe Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
Table 67 Europe Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
Table 68 Europe Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
Table 69 Europe Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
Table 70 Europe Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
Table 71 Europe Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
Table 72 Europe Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)
Table 73 Asia Pacific Human Microbiome Market Outlook, By Country (2013-2022) ($MN)
Table 74 Asia Pacific Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
Table 75 Asia Pacific Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 76 Asia Pacific Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 77 Asia Pacific Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
Table 78 Asia Pacific Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
Table 79 Asia Pacific Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
Table 80 Asia Pacific Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
Table 81 Asia Pacific Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
Table 82 Asia Pacific Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 83 Asia Pacific Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
Table 84 Asia Pacific Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 85 Asia Pacific Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
Table 86 Asia Pacific Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
Table 87 Asia Pacific Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
Table 88 Asia Pacific Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
Table 89 Asia Pacific Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
Table 90 Asia Pacific Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
Table 91 Asia Pacific Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
Table 92 Asia Pacific Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
Table 93 Asia Pacific Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
Table 94 Asia Pacific Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
Table 95 Asia Pacific Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
Table 96 Asia Pacific Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)
Table 97 RoW Human Microbiome Market Outlook, By Country (2013-2022) ($MN)
Table 98 RoW Human Microbiome Market Outlook, By Application (2013-2022) ($MN)
Table 99 RoW Human Microbiome Market Outlook, By Diagnostics (2013-2022) ($MN)
Table 100 RoW Human Microbiome Market Outlook, By Therapeutics (2013-2022) ($MN)
Table 101 RoW Human Microbiome Market Outlook, By Disease (2013-2022) ($MN)
Table 102 RoW Human Microbiome Market Outlook, By Cancer (2013-2022) ($MN)
Table 103 RoW Human Microbiome Market Outlook, By Acute Diarrhea (2013-2022) ($MN)
Table 104 RoW Human Microbiome Market Outlook, By Diabetes (2013-2022) ($MN)
Table 105 RoW Human Microbiome Market Outlook, By Mental Disorders (2013-2022) ($MN)
Table 106 RoW Human Microbiome Market Outlook, By Autoimmune Disorders (2013-2022) ($MN)
Table 107 RoW Human Microbiome Market Outlook, By Obesity (2013-2022) ($MN)
Table 108 RoW Human Microbiome Market Outlook, By Other Diseases (2013-2022) ($MN)
Table 109 RoW Human Microbiome Market Outlook, By Product (2013-2022) ($MN)
Table 110 RoW Human Microbiome Market Outlook, By Foods (2013-2022) ($MN)
Table 111 RoW Human Microbiome Market Outlook, By Drugs (2013-2022) ($MN)
Table 112 RoW Human Microbiome Market Outlook, By Probiotics (2013-2022) ($MN)
Table 113 RoW Human Microbiome Market Outlook, By Diagnostic Devices (2013-2022) ($MN)
Table 114 RoW Human Microbiome Market Outlook, By Prebiotics (2013-2022) ($MN)
Table 115 RoW Human Microbiome Market Outlook, By Medical Foods (2013-2022) ($MN)
Table 116 RoW Human Microbiome Market Outlook, By Nutritionally Incomplete Formulae (2013-2022) ($MN)
Table 117 RoW Human Microbiome Market Outlook, By Formulae for Metabolic Disorders (2013-2022) ($MN)
Table 118 RoW Human Microbiome Market Outlook, By Nutritionally Complete Formulae (2013-2022) ($MN)
Table 119 RoW Human Microbiome Market Outlook, By Oral Rehydration Products (2013-2022) ($MN)
Table 120 RoW Human Microbiome Market Outlook, By Other Probiotic Supplements (2013-2022) ($MN)



【レポートのキーワード】

ヒトマイクロバイオーム、食品、薬品、プロバイオティクス、診断装置、プレバイオティクス、医療食

★調査レポート[ヒトマイクロバイオームの世界市場見通し:食品、薬品、プロバイオティクス、診断装置、プレバイオティクス、医療食]販売に関する免責事項
★調査レポート[ヒトマイクロバイオームの世界市場見通し:食品、薬品、プロバイオティクス、診断装置、プレバイオティクス、医療食]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆